Can 3D image fusion make angioplasty safer by cutting radiation?
NCT ID NCT05353309
First seen Jun 30, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This trial investigates whether using 3D image fusion during iliac angioplasty reduces the amount of radiation patients receive compared to standard practice. The study involves 37 adults with iliac artery narrowing who need angioplasty. Researchers will measure radiation exposure in both groups to see if the newer imaging technique is safer.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If image fusion reduces radiation, it could make angioplasty safer for patients and staff.
- What could go wrong
- This is a small, early-stage study focused on radiation measurement, not clinical outcomes. The technique may not reduce radiation significantly or may have other drawbacks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
37 people
The number who actually took part.
- Started
-
May 2021
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient, male or female, over the age of 18 * Patient with a primary and/or external iliac lesion (TASC A, B and C) * Patient for whom unilateral angioplasty is indicated * Affiliated patient or beneficiary of a social security scheme * Patient having been informed and having signed a written consent. Exclusion Criteria: * Patient with a BMI strictly less than 18.5 or greater than or equal to 30.0 kg/m² * Patient with long iliac thrombosis (including the primitive iliac and the external iliac) * Patient with a known allergy to iodine * Patient with a contraindication related to the procedure * Patient for whom a bilateral iliac procedure is indicated * Patient requiring an associated infra-inguinal endovascular procedure * Patient participating in another clinical study * Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision * Pregnant, breastfeeding or parturient women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Iliac artery disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nantes
Nantes, Brittany Region, 44093, France
-
Saint Martin Private Hospital
Caen, Normandy, 14050, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.